. 2016 Mar 2;18(3):e23814. doi: 10.5812/ircmj.23814

Table 1. The Effect of the Oral Administration of Metformin, Acarbose, and Their Combination on Fasting Blood Glucose Levels and Glycated Hemoglobin in Normal and Nicotinamide/Streptozotocin-induced Type 2 Diabetic Rats^a,b.

Group	Serum Glucose Levels, mg/dL		HbA1c
Group	Day 0	Day 42	HbA1c
Normal	69.3 ± 3.90	77.1 ± 3.90	4.46 ± 0.27
Diabetic control	269.8 ± 22.0^c	295.8 ± 27.0^c	7.25 ± 0.79^c
Diabetic + metformin	307.0 ± 18.8^c	105.8 ± 11.3^c,d	4.91 ± 0.44^d
Diabetic + acarbose	277.1 ± 19.0^c	89.1 ± 6.3^d	4.21 ± 0.17^d
Diabetic + metformin and acarbose	258.6 ± 32.0^c	68.3 ± 2.9^d	3.80 ± 0.32^d

^aEach value is the mean ± SD of the six rats in each group.

^bA1c, diabetic control group compared with all other groups after day 42 (P = 0.0001); FBS, diabetic control group compared with all other groups after day 42 (P = 0.0001).

^cP < 0.05 as compared with normal rats.

^dP < 0.05 in comparison with diabetic rats.

Table 1. The Effect of the Oral Administration of Metformin, Acarbose, and Their Combination on Fasting Blood Glucose Levels and Glycated Hemoglobin in Normal and Nicotinamide/Streptozotocin-induced Type 2 Diabetic Ratsa,b.

Table 1. The Effect of the Oral Administration of Metformin, Acarbose, and Their Combination on Fasting Blood Glucose Levels and Glycated Hemoglobin in Normal and Nicotinamide/Streptozotocin-induced Type 2 Diabetic Rats^a,b.